Post-kala-azar dermal leishmaniasis
- PMID: 12560194
- DOI: 10.1016/s1473-3099(03)00517-6
Post-kala-azar dermal leishmaniasis
Abstract
Post-kala-azar dermal leishmaniasis (PKDL) is a complication of visceral leishmaniasis (VL); it is characterised by a macular, maculopapular, and nodular rash in a patient who has recovered from VL and who is otherwise well. The rash usually starts around the mouth from where it spreads to other parts of the body depending on severity. It is mainly seen in Sudan and India where it follows treated VL in 50% and 5-10% of cases, respectively. Thus, it is largely restricted to areas where Leishmania donovani is the causative parasite. The interval at which PKDL follows VL is 0-6 months in Sudan and 2-3 years in India. PKDL probably has an important role in interepidemic periods of VL, acting as a reservoir for parasites. There is increasing evidence that the pathogenesis is largely immunologically mediated; high concentrations of interleukin 10 in the peripheral blood of VL patients predict the development of PKDL. During VL, interferon gamma is not produced by peripheral blood mononuclear cells (PBMC). After treatment of VL, PBMC start producing interferon gamma, which coincides with the appearance of PKDL lesions due to interferon-gamma-producing cells causing skin inflammation as a reaction to persisting parasites in the skin. Diagnosis is mainly clinical, but parasites can be seen by microscopy in smears with limited sensitivity. PCR and monoclonal antibodies may detect parasites in more than 80% of cases. Serological tests and the leishmanin skin test are of limited value. Treatment is always needed in Indian PKDL; in Sudan most cases will self cure but severe and chronic cases are treated. Sodium stibogluconate is given at 20 mg/kg for 2 months in Sudan and for 4 months in India. Liposomal amphotericine B seems effective; newer compounds such as miltefosine that can be administered orally or topically are of major potential interest. Although research has brought many new insights in pathogenesis and management of PKDL, several issues in particular in relation to control remain unsolved and deserve urgent attention.
Similar articles
-
Leishmaniasis in Sudan. Post kala-azar dermal leishmaniasis.Trans R Soc Trop Med Hyg. 2001 Apr;95 Suppl 1:S59-76. doi: 10.1016/s0035-9203(01)90219-6. Trans R Soc Trop Med Hyg. 2001. PMID: 11370251
-
Leishmaniasis in Sudan. Visceral leishmaniasis.Trans R Soc Trop Med Hyg. 2001 Apr;95 Suppl 1:S27-58. doi: 10.1016/s0035-9203(01)90218-4. Trans R Soc Trop Med Hyg. 2001. PMID: 11370250
-
Post-kala-azar dermal leishmaniasis--an overview.Int J Dermatol. 2010 Aug;49(8):921-31. doi: 10.1111/j.1365-4632.2010.04558.x. Int J Dermatol. 2010. PMID: 21128917 Review.
-
Clinico-epidemiological analysis of Post kala-azar dermal leishmaniasis (PKDL) cases in India over last two decades: a hospital based retrospective study.BMC Public Health. 2015 Oct 26;15:1092. doi: 10.1186/s12889-015-2424-8. BMC Public Health. 2015. PMID: 26503551 Free PMC article.
-
Post-kala-azar dermal leishmaniasis in the Indian subcontinent: A threat to the South-East Asia Region Kala-azar Elimination Programme.PLoS Negl Trop Dis. 2017 Nov 16;11(11):e0005877. doi: 10.1371/journal.pntd.0005877. eCollection 2017 Nov. PLoS Negl Trop Dis. 2017. PMID: 29145397 Free PMC article. Review.
Cited by
-
Evidence for involvement of Th17 type responses in post kala azar dermal leishmaniasis (PKDL).PLoS Negl Trop Dis. 2012;6(6):e1703. doi: 10.1371/journal.pntd.0001703. Epub 2012 Jun 19. PLoS Negl Trop Dis. 2012. PMID: 22724038 Free PMC article.
-
Xenodiagnosis to address key questions in visceral leishmaniasis control and elimination.PLoS Negl Trop Dis. 2020 Aug 13;14(8):e0008363. doi: 10.1371/journal.pntd.0008363. eCollection 2020 Aug. PLoS Negl Trop Dis. 2020. PMID: 32790716 Free PMC article. Review.
-
Stigma associated with cutaneous and mucocutaneous leishmaniasis: A systematic review.PLoS Negl Trop Dis. 2023 Dec 28;17(12):e0011818. doi: 10.1371/journal.pntd.0011818. eCollection 2023 Dec. PLoS Negl Trop Dis. 2023. PMID: 38153950 Free PMC article.
-
A case report on para-kala-azar dermal leishmaniasis: an unresolved mystery.BMC Infect Dis. 2023 Dec 18;23(1):885. doi: 10.1186/s12879-023-08918-1. BMC Infect Dis. 2023. PMID: 38110894 Free PMC article.
-
DNA polymorphism assay distinguishes isolates of Leishmania donovani that cause kala-azar from those that cause post-kala-azar dermal Leishmaniasis in humans.J Clin Microbiol. 2004 Apr;42(4):1739-41. doi: 10.1128/JCM.42.4.1739-1741.2004. J Clin Microbiol. 2004. PMID: 15071036 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
